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 The self-nanoemulsifying drug delivery system (SNEDDS), is a promising Drug Delivery 
System which is well known for its prospective to improve the aqueous solubility and oral 
absorption of poorly water soluble drugs (Pouton, 2000). SNEDDS is an isotropic mixture 
comprising oil, surfactant, co-surfactant and drug that form oil in water emulsion in aqueous 
environment under placid agitation. It can readily disperse in the aqueous environment of the 
gastrointestinal tract to form a fine oil-in-water emulsion with a droplet size not exceeding 
100 nm under mild agitation for improving the oral bioavailability of poorly water-soluble 
drugs (Shah et al.,  1994; Constantinides, 1995). Compared to conventional metastable 
emulsions, SNEDDS is a thermodynamically stable formulation with high solubilization 
capacity for lipophilic drugs, and also can be filled directly into soft or hard gelatin capsules 
for convenient oral administration. The Self nano-emulsifying Drug Delivery System 
(SNEDDS) is applicable on BCS Class II and Class IV Drugs for improving water Solubility 
of poorly water soluble drugs. It is important to prevent the interfacial tension and improving 
the dissolution as well as absorption rate of drug molecule. It is the novel drug delivery 
system which is applicable for parenteral, ophthalmic, intranasal and cosmetic delivery of 
drugs. The review presents an overview of  design of formulation, preparation of components, 
mechanism of self nano emulsification, biopharmaceutical aspects, characterization methods 
and applications of self nano-emulsifying drug delivery system (SNEDDS) for enhancement 
of oral bioavailability of poorly water soluble drugs. 
Please cite this article in press as Dash Tapaswi Rani et al. Novel Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) for 
Oral Delivery of Lipophilic Drugs. Indo American Journal of Pharmaceutical Research.2017:7(01). 
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INTRODUCTION 
As Oral route is the most preferred route for dministration of drugs, but majority of drugs are frequently administered through 
oral route because of first pass metabolisim. But about 40% of new drug candidates have poor aqueous solubility and the oral delivery 
of such drugs is complicated because of the reason that of their low bioavailability, high inter/intra‐subject variability, and no dose 
linearity.
(1,2) 
To overcome all these problems, different strategies have been developed including the use of lipids, permeation enhancers, 
surfactants, micronization, salting in/out, cyclo-dextrins, nanonisation and solid dispersions etc. There has been evolving attention in 
the use of lipid excipients in self‐emulsifying lipid formulations (SELFs) because of their competency to solubilize poorly 
water‐soluble lipophilic drugs and to prevail over the problem of poor drug absorption and bioavailability. (3,4) 
Novel approaches include microemulsions, nanoemulsions, self-emulsifying formulations, self-microemulsifying 
formulations, and self-nanoemulsifying formulations. Most of them advantageously increase surface area of the drugs to improve 
solubility behavior, as well as permeation characteristics.
 (5, 6)
 
Self-nanoemulsifying drug delivery systems (SNEDDS) are nanoemulsion preconcentrates or anhydrous forms of 
nanoemulsion. These systems are lipid isotropic mixtures of drug, oil and surfactant(s) when introduced into aqueous phase under with 
aide of gentle agitation, spontaneously form O/W nanoemulsions (usually with globule size > 200 nm).In human body, the agitation 
required for formation of nanoemulsions is provided by digestive motility of the GI tract. SNEDDS may also contain co-emulsifier or 
co-surfactant and/or solubilizer in order to facilitate nanoemulsification or improve the drug incorporation in SNEDDS.
 (7)
 
Nanoemulsions are heterogeneous dispersions of two liquids (oil-in-water or water-in-oil) regardless of method of 
preparation; they have mean droplet size in the nano scale (20–200 nm). These heterogeneous dispersions were initially known as 
submicron emulsions; miniemulsions, ultrafine and microemulsions, and regrettably these systems are confused with micro emulsions, 
which are thermodynamically stable. 
(8, 9) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Different types of self-emulsifying therapeutic system 
 
 
Self-emulsifying drug delivery systems (SEDDS) are isotropic mixtures of oil, surfactant, surfactant and co- surfactant that 
form fine oil-in-water or water-in-oil emulsion when introduced into aqueous medium under gentle. The design of effective 
formulation for drugs has long been a major challenge, because drug efficacy can be severely limited by instability or poor solubility 
in the vehicle.  
Due to higher solubilization capacity of nanoemulsion/ microemulsion, they have more thermodynamic stability and offers 
advantages over unstable dispersions, such as emulsions and suspensions, because they can be manufactured with little energy input 
(heat or mixing) and has a long shelf life.  In case of nanoemulsion, due to the nanosized droplets, there is enormous interfacial area 
which influences the transport properties of the drug, an important factor  influencing the sustained and targeted drug delivery. Also 
the oily formulations such as microemulsions lead to lymphatic drug absorption and thus by-passes the liver, which is the major site of 
drug metabolism. The desirability of o/w nanoemulsion system lays in their ability to incorporate hydrophobic drugs into the oil phase 
thereby enhancing their solubility. Nanoemulsions have been reported to make the plasma concentration profiles and bioavailability of 
drugs more reproducible.  
Although nanoemulsions are one of the best choice for hydrophobic drug delivery system, but being a liquid dosage form it 
would not be as popular as the solid dosage form. So to cope-off these challenges many attempts have been taken to convert liquid 
self-emulsifying system to the solid self-emulsifying drug delivery system. 
SELF EMULSIFYING THERAPEUTIC SYSTEM 
SELF EMULSIFYING 
FORMULATIONS 
 Oil droplet size 200nm-
5µm 
 Appearance- Turbid 
 Required HLB value- <12 
 Development may require 
characterization of ternary 
phase diagram 
SELF-MICROEMULSIFYING 
FORMULATIONS 
 Oil droplet size100-250 nm 
 Appearance- optically clear to 
translucent 
 Required HLB value >12 
 Development may require 
characterization of pseudo 
ternary phase diagram. 
 
SELF-NANOEMULSIFYING 
FORMULATIONS 
 Oil droplet size >100nm 
 Optically clear appearance 
 Required HLB value >12 
 Development may require 
characterization of pseudo 
ternary phase diagram 
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SNEDDS are defined as isotropic mixtures of natural or synthetic oils containing solid or liquid surfactants and one or more 
hydrophilic solvents. They form fine oil in water (o/w) emulsions on contact with GI fluids. Usually the drug in SNEDDS remains in 
the solution form throughout its GI transit time whereby they circumvent the dissolution step. It involves digestion of the excipients 
and formation of different colloidal structures as nanodroplets. The drug gets partitioned into these structures before it is absorbed. 
The nanodroplets formed are with increased surface area due to decreased interfacial tension and thus they are readily available for 
absorption of poorly soluble drugs. In addition to increased surface area the common excipients used in the formulation of SNEDDS 
inhibits P-gp & CYP450 enzymes thereby decreasing intestinal efflux and drug biotransformation respectively. Research also reveals 
that SNEDDS facilitates the transcellular and paracellular absorption thereby the drug is absorbed through the lymphatics via 
chylomicron sysnthesis of the fatty components of the oil phase of the emulsion , thus inhibiting first pass metabolism of drug. 
Furthermore, pharmaceutical microemulsions require a high surfactant concentration (about ~20% or more) to enable optimal 
drug delivery, nanoemulsions can be fabricated with a relatively small concentration of surfactant (3–10%). 
SNEDDS contains diverse class of excipients which may affect the performance of a dosage form in various forms. Hence, 
application of experimental methods like factorial design, Box–Behnken design (BBD), D-optimal design, and mixture design etc for 
systematic optimization helps in optimizing drug delivery systems to obtain better formulations. Further drug-loaded SMEDDS can be 
converted into free flowing solid granules (S-SNEDSS) using porous carriers like Aerosil 200, Sylysia (350, 550, and 750) and 
Neusilin US2 by adsorption technique.
(10,11) 
 
Self Nano emulsifying Drug Delivery Systems for Oral Drug Delivery 
The oral route is the most complimented and preferred route of drug delivery. However, more than 50% of drugs delivered 
via oral route have limited therapeutic efficacy due to poor water solubility.
(12) 
Furthermore, a majority of the new chemical moieties being generated through drug discovery programs also exhibit poor 
aqueous solubility. The problems associated with such drugs include erratic absorption profile, poor oral bioavailability, high intra/ 
inter-subject variability and lack of dose proportionality. 
(13) 
The ability of nano-sized/submicronic emulsions to improve the GI absorption of lipophilic drugs was demonstrated almost 
three decades ago.
 (14) 
 
Factors affecting SNEDDS 
 Very high dose drugs  are not  the suitable candidate  for SNEDDS, unless they exhibit extremely good solubility in at least one of 
the components of SNEDDS, preferably lipophillic phase. The drugs exhibit limited solubility in water and lipids are most 
complicated to deliver by SNEDDS. 
  The ability of SNEDDS to maintain the drug in solubilized form is greatly affected by the solubility of the drug in lipid phase. If 
the surfactant/co-surfactant is contributing to a greater extent for drug solubilization, then there may be a chance of precipitation, 
as dilution of SNEDDS will cause lowering of solvent capacity of surfactant or co-surfactant.
(15)
 
 
Suitable drug candidate identification for SEDDS 
For lipophilic drug compounds that exhibit dissolution-rate-limited absorption, SEDDS can offer an improvement in rate and 
extent of absorption, resulting in reproducible blood time profiles. Logically speaking, however, use of SEDDS can be extended to all 
four categories of biopharmaceutical classification system (BCS) class drugs.
(16)
 
 
Potential advantages of these systems include 
1. Enhanced oral bioavailability enabling reduction in dose such as Ketoprofen (17) 
2. More consistent temporal profiles of drug absorption e.g. Ontazolast (18) 
3. Selective targeting of drug(s) toward specific absorption window in GIT (19) 
4. Protection of drug(s) from the hostile environment in gut e.g. Acetylsalicylic acid (20) 
5. Control of delivery profiles e.g. Paclitaxel (21) 
6. Reduced variability including food effects e.g. Cyclosporine (22) 
7. Protective of sensitive drug substances (19) 
8. High drug payloads (19) 
9. Liquid or solid dosage forms e.g. Progesterone (23) 
10. Emulsion cannot be autoclaved as they have phase inversion temperature, while SMEDDS can be autoclaved (19) 
 
Mechanism of self-emulsification 
According to Reiss; self-emulsification occurs when the entropy change that favors dispersion is greater than the energy 
required to increase the surface area of the dispersion. The free energy of the conventional emulsion is a direct function of the energy 
required to create a new surface between the oil and water 
(24)
. 
 
ΔG = Σ N π r2 σ 
 
Where, ΔG is the free energy associated with the process, N is the number of droplets of   radius r and σ represents the interfacial 
energy. 
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The two phases of emulsion tend to separate with time to reduce the interfacial area and, subsequently, the emulsion is 
stabilized by emulsifying agents, which form a monolayer of emulsion droplets, and hence reduces the interfacial energy, as well as 
providing a barrier to prevent coalescence 
(25, 26)
. 
 
Composition of SEDDS and SMEDDS 
Oils: 
Modified or hydrolyzed vegetable oils have contributed widely to the success of SEDDS owing to their formulation and 
physiological advantages. Novel semi-synthetic medium-chain triglyceride oils have surfactant properties and are widely replacing the 
regular medium- chain triglyceride 
(27,28)
. Long-chain triglyceride and medium-chain triglyceride oils with different degrees of 
saturation are also valuable in designing of SEDDS. 
 
Surfactant: 
The choice of surfactants is limited as very few surfactants are orally acceptable. Non-ionic surfactants with high HLB value 
are used in formulation of SMEDDS including: Ethoxylated polyglycolysed glyceride, Tween 80, LABRFAC CM1O-a mixture of 
saturated compounds containing 8 carbon polyglycolysed glycosides and other long chain alkyl sulfonate sulfate surfactants, such as 
sodium dodecyl benzene sulfonate, sodium lauryl sulfate and dialkyl sulfo succinate and quaternary ammonium salts, fatty alcohols 
such as lauryl, cetyl and stearyl, glyceryl esters, fatty acid esters and polyoxyethylene derivatives are also, employed. 
Emulsifiers derived from natural sources are expected to be safer than synthetic ones and are recommended for SMEDDS use despite 
their limited ability to self emulsify. Non-ionic surfactants are known to be less toxic compared to ionic surface-active agents. The 
high HLB and subsequent hydrophilicity of surfactants is necessary for the immediate formation of o/w droplets and /or rapid 
spreading of the formulation in the aqueous environment, providing a good dispersing/self-micro emulsifying performance 
(29)
. 
 
Co-surfactant: 
In SMEDDS, generally cosurfactant of HLB value 10-14 is used. Hydrophilic co-surfactants preferably alcohols of 
intermediate chain length such as hexanol, pentanol and octanol which are known to reduce the oil water interface and allow the 
spontaneous formulation of micro emulsion 
(27)
, are used in formulation of SMEDDS. 
 
Cosolvents: 
Cosolvents may help to dissolve large amounts of hydrophilic surfactants or the hydrophobic drug in the lipid base which are 
as follows diethylene glycol, monoethyl ether (transcutol), propylene glycol, polyethylene glycol, polyoxyethylene, propylene 
carbonate, etc 
(27)
. 
 
Consistency builder: 
Materials such as tragacanth, cetyl alcohol, stearic acids and /or beeswax 
(30)
 are added to alter the consistency of emulsion. 
 
METHODOLOGIES 
Solubility Studies 
The solubility of drug in various oils, surfactants, co-surfactants and Oil; surfactant mixture was measured using shake flask 
method (8 - 12). An excess amount of Drug was added into each vehicle followed by vortex mixing for 30 sec (Remi mixer, Mumbai). 
Mixtures were shaken for 48 h at 30
oC
 in a thermostatically controlled shaking water bath, followed by equilibrium for 24 hr. Mixtures 
were then centrifuged at 3000 rpm for 10 min and the supernatant was filtered through a Millipore membrane filter (0.45μ). Samples 
were suitably diluted with methanol and drug concentration was obtained via UV validated method. 
 
Preliminary screening of surfactants 
Different surfactants for the oral use were screened for emulsification ability. Briefly, 150 mg of the surfactants were added 
to 150 mg of the oily phase. The mixtures were gently heated at 50
0
C for homogenization of the components. Each mixture, 100 mg, 
was then diluted with distilled water to 100 ml in a stoppered conical flask. Ease of emulsification was judged by the number of flask 
inversions required to yield homogenous emulsion. Emulsions were allowed to stand for 2 h and their % transmittance was evaluated 
by UV-Visible spectrophotometer (Shimadzu, Japan) using distilled water as a blank. Emulsions were furthermore observed visually 
for any turbidity or phase separation. 
 
Preliminary screening of co-surfactants 
The selected oily phase and surfactant were used for further screening of the different co-surfactants for their emulsification 
ability. Mixtures of 200 mg of co-surfactant, 400 mg cremophor RH40, and 600 mg Sunflower oil were prepared and evaluated in a 
similar fashion as described in preliminary screening of surfactants. 
 
Phase diagram Study: 
In a pseudo-ternary phase diagram study, systems consisting of oil, surfactant, and as co-surfactant were titrated with water, 
and self-emulsifying formulations were selected observing regions of infinite dilution. 
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Formulation of SNEDDS: 
A series of SNEDDS formulations were prepared using Surfactant/ co-surfactant combination and oil. Briefly, accurately 
weighed drug was placed in a glass vial and oil, surfactant, and co-surfactant were added. Then the components were mixed by gentle 
stirring on a magnetic stirrer and subjected to vortexing using a cyclomixer (Remi, India) until drug was perfectly dissolved to get 
atransparent prepration. Then  all the mixtures were stored at room temperature for further use. 
 
EVALUATION OF SNEDDS 
Self Emulsification and Phase Separation 
Various compositions were categorized on speed of emulsification, clarity, and apparent stability of the resultant emulsion 
(15, 
16)
. Visual assessment was performed by drop wise addition of the preconcentrate (SNEDDS) into 100, 250 and 1000 mL of distilled 
water, 0.1N HCl and pH 6.8 phosphate buffer taken in a glass beaker at room temperature, and the contents were gently stirred with 
glass rod or in a magnetic stirrer at a speed of 100rpm.  Immediately they were observed after dilution for assessment for self-
nanoemulsification efficiency, appearance (transparency), phase separation, and precipitation of drug.Precipitation was evaluated by 
visual inspection of the resultant emulsion after 24 hours. The formulations were then categorized as clear (transparent or transparent 
with bluish tinge), non clear (turbid), stable (no precipitation at the end of 24 hours), or unstable (showing precipitation within 24 
hours). The tendency to form an emulsion is assessed as “good”when emulsification occurs rapidly in less than 1 minute with clear 
(or) transparent appearance. The tendency to form an emulsion is assessed as “bad” when there is less clear emulsion formation. 
Depending on visual appearance and time taken for self emulsification, formulations are graded as: 
(46) 
 
Grade A: Rapidly forming (within 1min) nano emulsion having a clear (or)  bluish appearance. 
Grade B: Rapidly forming, slightly less clear emulsion, having a bluish white appearance.  
Grade C: Fine milky emulsion that formed within 2 minutes. 
Grade D: Dull, grayish white emulsion with a slight oily appearance that is slow to emulsify (more than 2 minutes).  
Grade E: Formulation Exhibiting either poor or minimal emulsification with large oil lobules present on the surface.  
 
Emulsion Droplet Size 
The average droplet size is a decisive factor in self-emulsification performance because it will determine the rate and extent 
of drug release, as well as the stability of the emulsion [80]. Dynamic light scattering (DLS) techniques, photon correlation 
spectroscopy and microscopic techniques are mainly used for the determination of the emulsion droplet size and Polydispersity index. 
DLS is ideal for measuring particles or droplets in the diameter of 3 nm to 3 mm. Droplet size distributions can be further verified by 
cryogenic transmission electron microscopy (cryo-TEM), which offers the possibility to observe the droplet’s size and shape. The poly 
dispersity index of SNEDDS reflects the uniformity of particle diameter and can be used to depict the size distribution of nano 
emulsion droplets. 
 
Zeta Potential  
Zeta potential is used to identify the charge of the oil droplets of SEDDS. The charge of the oil droplets in conventional 
SEDDS is negative due to the presence of free fatty acids [96]. For the droplets in SEDDS emulsions, a high zeta potential will confer 
stability and long shelf life. When the potential is low, attractive forces may exceed this repulsion and the emulsion may break and 
aggregate. Some investigators consider zeta potential as secondary characterization parameter for SEDDS, because SEDDS are 
preconcentrate mixture of drug in oil and surfactant and emulsified in vivo only. The zeta potential of SEDDS emulsion is commonly 
investigated using Malvern Zeta Sizer and the zeta potential values are calculated using Smoluchowski equation.
 (47) 
  
 
Ternary phase diagrams  
Ternary orPseudo ternary phase diagrams are normally constructed with the oil phase, surfactant or mixture of surfactant and 
co-surfactant, and the aqueous phase, which will reveal the regions of liquid crystal, microemulsion (w/o or o/w) and coarse emulsion 
(9)
. Ternary phase diagrams enable comparison of different surfactants and their synergistic effect with co-surfactant. They can also 
help to determine the optimum concentration ranges of different excipients and to identify the self-emulsification regions. The 
boundaries of different phase regions can easily be assessed visually. 
 
Emulsification time 
With the purpose of quantifying the efficiency of emulsification of SEDDS. Pouton 
(1)
 employed the rotating paddle to 
promote emulsification in a crude nephelometer. This enabled an estimation of the time taken for emulsification. On completion of 
emulsification, the SEDDS samples were taken for particle sizing by photon correlation spectroscopy, and further by other 
characterizations. 
 
Turbidity measurement 
The turbidity measurements can be carried out to identify the efficient self-emulsification by establishing whether the 
dispersion reaches equilibrium rapidly and in a reproducible time. These measurements are commonly carried out on turbidity meters, 
and also can be processed in terms of spectroscopic characterization of optical clarity (i.e. absorbance of suitably diluted aqueous 
dispersion at 400 nm). 
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Refractive index and Percentage Transmittance  
Refractive index and percent transmittance proved the transparency of formulation. The refractive index of the system is 
measured by refractometer by placing drop of solution on slide and compared with water (1.333).The percentage transmittance of the 
system is measured at particular wavelength using UV-spectrophotometer keeping distilled water as blank. If refractive index of 
system is similar to the refractive index of water (1.333) and formulation have percentage transmittance > 99 percent, then formulation 
is of transparent nature.  
 
Morphology  
The morphology of the nanoemulsion droplets can be evaluated by Cryo-Transmission Electron Microscopy (Cryo-TEM), 
small-angle neutron scattering and 42 small-angle X-ray scattering. Cryo-TEM and small-angle neutron scattering offer the advantage 
of vizualising the particle sizes and shapes. Furthermore, droplets size distributions can be further verified by cryo-TEM. Small-angle 
X-ray scattering is used to determine the microscale or nanoscale structure of particle systems in terms of such parameters as averaged 
particle sizes, shapes, distribution and surface-to-volume ratio.  
 
Viscosity 
The rheological properties of the SEDDS formulations are useful to assess their ability to be filled in the soft or hard gelatin 
capsules. The viscosity of formulations should not be high to create problem in pourability. Conversely, low viscosity may lead to 
leakage from the capsules.  
 
Drug Content 
SNEDDS containing drug was added in volumetric flask containing methanol. The mixture was stirred vigorously for 2 hr. 
The sample was analysed for drug concentration after suitable dilution using UV –spectrophotometer. 
 
In Vitro Dissolution 
The in vitro dissolution studies were performed to evalu-ate the release efficiency of the optimal formulations. Based on the 
drug content determinations self nanoemulsifying formulations were filled in hard gelatin capsule shells. The dissolution was carried 
out using dissolution test apparatus USP Type II with a paddle stirrer, maintained at 37±5
o
C, 50 rpm paddle speed. Dissolution was 
performed in two different mediums viz. 0.1N HCl ( Simulated gastric fluid) and 6.8 pH Phosphate buffer 900 ml. The samples were 
withdrawn at predetermined time intervals and were analyzed for drug concentration by UV-Visible spectrophotometer after filtration 
through 0.22 μ filter. 
 
CONCLUSION 
Self Nanoemulsifying drug delivery system (SNEDDS) is a novel approach for the formulation of poorly water soluble drugs 
as they have high potential to improve the Bioavailability. Self Nanoemulsifying drug delivery system (SNEDDS) is an  isotropic 
mixture of oils, surfactants, Cosurfactant and co-solvent. When introduced into aqueous phase, it emulsifies spontaneously to produce 
fine o/w Nanoemulsion under gentle stirring. By the formulation of SNEDDS  it exhibits significant improvement of drug solubility, 
rapid dissolution rate together with the enhanced permeation. The oral delivery of poorly water soluble drugs can be made possible by 
SNEDDS by improving oral bioavailability. By using this approach it is possible to prolong the release of drug via incorporation of 
polymer in composition. SNEDDS seems to be appearing as unique and having industrial survivability for future development. 
and the unique characteristics of this lipid-based dosage form present significant challenges to scientists in many ways like,  the safety 
issues need to be considered, particularly when a new excipient is used in the formulation.  
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